Nine states in the Southeast showed growth in bioscience employment and establishments from 2019 to 2023, according to 2024 ...

Strategic acquisition marks significant step to establish pan-European footprint and deepens expertise in oncology and early-phase biotech clinical trials.

Trump’s tariffs and the global trade war continue to affect markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.

Having already worked with clinical trial sites in more than 14 states, CTAC will now take its work nationwide, the ...

Bharat Biotech to launch Hillchol, its oral cholera vaccine, amid a global shortage. With Phase III trials completed and 200M ...

"We are proud to partner with Kaida BioPharma on the development of KAD101,” said Prof. Vladas Algirdas Bumelis, CEO and ...

Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...

Hyderabad-based Bharat Biotech International Ltd. has claimed that its oral cholera vaccine (OCV) under development, Hillchol ...

Known to develop the next generation of vaccines and medicines, with a focus on cell and gene therapies, the company started ...

Healthcare Patent Filing Outsourcing Market, revealing compelling growth prospects over the next decade. According to the ...

The US Department of Health and Human Services is demanding that pharmaceutical companies cut drug prices to the lowest price ...

Following President Trump's Most Favored Nation executive order, HHS and CMS have released the target price for pharmaceutical manufacturers to meet.